Journal Information
Full text access
Is tolvaptan (a vasopressin V2 receptor antagonist) effective in the management of isovolumic and hypervolaemic hypernatremia?
¿El tolvaptán, un antagonista de los receptores de la vasopresina V2, ¿es un tratamiento eficaz para la hiponatremia euvolémica e hipervolémica?
Visits
3092
F. Ortiz
This item has received
Article information